Literature DB >> 12473860

Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men.

Jarkko Karvonen1, Heikki Kauma, Kari Kervinen, Olavi Ukkola, Maire Rantala, Markku Päivänsalo, Markku J Savolainen, Y Antero Kesäniemi.   

Abstract

OBJECTIVE: Smoking is a risk factor for increased carotid artery intima-media thickness (IMT). The apolipoprotein E (apoE) 4 allele has been associated with cardiovascular diseases, but the role of apoE in regard to intima-media thickness (IMT) has remained controversial. The objective was to investigate whether there is some gene-environment interaction between smoking and apoE polymorphism. DESIGN Cross-sectional case-control study.
METHODS: IMTs of 511 hypertensive and control men were measured ultrasonographically and the apoE genotypes were determined. Genotypes with the 4 allele were pooled into one group and the genotypes without it into another.
RESULTS: A significant interaction between the 4 allele and smoking affecting IMT was observed among the hypertensive smokers, as assessed by analysis of covariance. The mean carotid IMT was significantly greater (1.01 versus 0.90 mm, P = 0.003) in the 4 carriers than in the subjects without 4 among the hypertensive smokers. The number of plaques was also significantly higher. No differences were found in the other subjects (hypertensive non-smokers or controls). Linear regression analysis indicated that the 4 allele was an independent determinant of IMT in the hypertensive smokers but not in the other subjects. The estimated average effect of the 4 allele on the mean IMT in the hypertensive smokers was 0.088 mm (P < 0.001). In the oldest age group, the interaction of smoking and 4 was also seen in the control subjects.
CONCLUSION: The findings suggest that the 4 carriers are particularly susceptible to the atherogenic effects of smoking. This interaction is particularly clear in hypertensive subjects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473860     DOI: 10.1097/00004872-200212000-00015

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.

Authors:  Santiago Rojas; Anna Brugulat-Serrat; Nuria Bargalló; Carolina Minguillón; Alan Tucholka; Carles Falcon; Andreia Carvalho; Sebastian Morán; Manel Esteller; Nina Gramunt; Karine Fauria; Jordi Camí; José L Molinuevo; Juan D Gispert
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-11       Impact factor: 6.200

Review 2.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

Review 3.  Association between apolipoprotein E genotype and carotid intima-media thickness may suggest a specific effect on large artery atherothrombotic stroke.

Authors:  Lavinia Paternoster; Nahara Anáni Martínez González; Steff Lewis; Cathie Sudlow
Journal:  Stroke       Date:  2007-12-06       Impact factor: 7.914

4.  Effect of Apolipoprotein E ε4 Allele on the Progression of Carotid Atherosclerosis Through Apolipoprotein Levels.

Authors:  Wenbing Ma; Liting Zhang; Suya Zhang; Lei Luo; Shuang Yang; Hongping Yao; Lei Zhang; Xiaoyun Lu; Weiyi Feng
Journal:  Pharmgenomics Pers Med       Date:  2022-06-21

5.  Apolipoprotein E epsilon4 genotype is independently associated with increased intima-media thickness in a recessive pattern.

Authors:  M Wohlin; J Sundström; Lars Lannfelt; Tomas Axelsson; A C Syvänen; B Andrén; S Basu; L Lind
Journal:  Lipids       Date:  2007-04-11       Impact factor: 1.646

6.  Cigarette smoke exposure impairs reverse cholesterol transport which can be minimized by treatment of hydrogen-saturated saline.

Authors:  Chuanlong Zong; Guohua Song; Shutong Yao; Shoudong Guo; Yang Yu; Nana Yang; Zheng Guo; Shucun Qin
Journal:  Lipids Health Dis       Date:  2015-12-03       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.